Summary & Overview
HCPCS Level II J8498: Antiemetic Drug, Rectal Suppository
HCPCS Level II code J8498 identifies an antiemetic medication supplied as a rectal suppository, coded as not otherwise specified. This code matters nationally as it captures billing for an alternative route of antiemetic therapy used across inpatient and outpatient settings when oral or intravenous administration is impractical. Accurate use of J8498 affects pharmacy billing, outpatient drug claims, and facility reimbursement workflows.
Key payers included in analyses of this code are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical context for rectal antiemetic use, common sites of service where the code is applied, and how the code integrates into pharmacy and facility claim lines. The publication outlines available benchmarks and coverage considerations, notes common billing modifiers used with similar injectable and oral drug codes (modifier detail lists follow elsewhere), and highlights areas where payers commonly require additional documentation.
This national overview provides the clinical definition, expected service scenarios, and a roadmap to the billing and policy topics readers can expect: claim line construction, payer coverage patterns, and coding nuances for non-oral antiemetic delivery. Data not available in the input.
Billing Code Overview
HCPCS Level II code J8498 denotes an antiemetic drug administered as a rectal suppository, classified as “not otherwise specified.” This billing code represents pharmaceutical treatment intended to prevent or control nausea and vomiting when an oral or parenteral route is unsuitable or not tolerated.
-
Service type: Medication administration via rectal suppository
-
Typical site of service: Outpatient clinics, emergency departments, hospital inpatient units, and other settings where rectal medication delivery is clinically indicated
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric patient experiencing moderate to severe nausea and vomiting who cannot tolerate oral antiemetics or where rectal administration is clinically preferred (e.g., persistent vomiting, recent oral surgery, inability to swallow, malabsorption, or postoperative nausea when IV access is limited). The patient presents in an emergency department, ambulatory surgical center, inpatient ward, or clinic; a prescriber orders a rectal/suppository antiemetic. A nurse or licensed clinician prepares and administers the suppository following medication administration protocols, documents lot number, dosage, route rectal, time of administration, patient response, and any adverse effects. Typical workflow steps include medication order entry, allergy and interaction check, informed consent or patient acknowledgement if required, preparation and administration, monitoring for effectiveness and sedation, and documentation in the medical record. Billing uses HCPCS Level II code J8498 for the medication supply when the product is billed separately; facility and professional charges for administration may be reported with appropriate CPT/HCPCS administration or evaluation codes as applicable. Usual sites of service are hospital inpatient units, emergency departments, ambulatory surgery centers, and outpatient clinics where rectal medication delivery is clinically indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |